Genertec Universal Medical Group Company Limited (HKG:2666)
Hong Kong · Delayed Price · Currency is HKD 4.830
+0.030 (0.63%)
Jul 30, 2026, 4:08 PM HKT
HKG:2666 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,108 | 2,379 | 2,849 | 2,705 | 2,342 |
Long-Term Investments | 226.95 | 275.42 | 990.05 | 1,034 | 986.86 |
Trading Asset Securities | - | 160.69 | 309.33 | 131.61 | - |
Loans & Lease Receivables | 70,022 | 71,577 | 67,262 | 64,883 | 60,565 |
Other Receivables | 577.31 | 711.52 | 526.31 | 517.99 | 248.86 |
Property, Plant & Equipment | 7,777 | 7,627 | 5,553 | 4,975 | 3,318 |
Goodwill | 384.3 | 381 | 286.54 | 102.25 | 102.25 |
Other Intangible Assets | 284.11 | 303.79 | 161.27 | 79.17 | 46.18 |
Other Current Assets | 872 | 814.76 | 849.54 | 938.97 | 1,090 |
Long-Term Deferred Tax Assets | 872.13 | 773.88 | 702.16 | 742.55 | 561.18 |
Other Long-Term Assets | 262.55 | 520.95 | 424.67 | 482.44 | 374.14 |
Total Assets | 84,318 | 86,032 | 80,345 | 76,980 | 69,900 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2,905 | 2,776 | 2,989 | 2,294 | 1,112 |
Accrued Expenses | 1,602 | 1,077 | 1,221 | 1,129 | 1,195 |
Short-Term Debt | 6,523 | 5,456 | 6,601 | 2,519 | 3,878 |
Current Portion of Long-Term Debt | 13,255 | 16,040 | 15,879 | 17,513 | 10,094 |
Current Portion of Leases | 52.52 | 692.66 | 84.25 | 807.94 | 1,120 |
Long-Term Debt | 28,015 | 29,271 | 24,866 | 26,010 | 28,855 |
Long-Term Leases | 491.55 | 561.84 | 245.92 | 181.99 | 779.75 |
Long-Term Unearned Revenue | 108.5 | 114.23 | 28.93 | 21.25 | 12.09 |
Current Income Taxes Payable | 131.91 | 164.37 | 119.64 | 84.1 | 109.61 |
Other Current Liabilities | 1,345 | 2,053 | 2,931 | 1,851 | 1,074 |
Pension & Post-Retirement Benefits | 91.71 | 88.35 | 82.95 | 84.92 | 88.51 |
Other Long-Term Liabilities | 4,315 | 4,509 | 4,679 | 4,499 | 3,810 |
Total Liabilities | 59,279 | 63,163 | 59,977 | 57,260 | 52,277 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5,984 | 5,297 | 5,297 | 5,297 | 5,297 |
Retained Earnings | 13,342 | 11,789 | 10,365 | 9,008 | 7,705 |
Comprehensive Income & Other | 1,617 | 1,767 | 1,688 | 1,335 | 1,763 |
Total Common Equity | 20,943 | 18,854 | 17,350 | 15,641 | 14,766 |
Minority Interest | 4,096 | 4,016 | 3,018 | 4,080 | 2,857 |
Shareholders' Equity | 25,039 | 22,870 | 20,368 | 19,721 | 17,623 |
Total Liabilities & Equity | 84,318 | 86,032 | 80,345 | 76,980 | 69,900 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 48,337 | 52,022 | 47,676 | 47,032 | 44,727 |
Net Cash (Debt) | -46,230 | -49,482 | -44,518 | -44,195 | -42,385 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -22.96 | -24.62 | -21.37 | -21.28 | -20.80 |
Filing Date Shares Outstanding | 2,014 | 1,892 | 1,892 | 1,892 | 1,892 |
Total Common Shares Outstanding | 2,014 | 1,892 | 1,892 | 1,892 | 1,892 |
Working Capital | 48,254 | 47,533 | 42,154 | 43,102 | 45,780 |
Book Value Per Share | 10.40 | 9.97 | 9.17 | 8.27 | 7.81 |
Tangible Book Value | 20,274 | 18,169 | 16,902 | 15,459 | 14,617 |
Tangible Book Value Per Share | 10.07 | 9.61 | 8.94 | 8.17 | 7.73 |